Administration of interferon for prophylaxis against or treatment of pathogenic infection
US8309531B2 · kind B2 · utility
2Cited by
21References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2010 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Jun 16, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-α), and are provided to the subject by, e.g., intranasal or pulmonary administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.